Characteristics | Total N = 111 | With CRS N = 70 | Without CRS N = 41 | OR (CI 95%) | P value |
Gender |
|
|
|
|
|
Male | 72 (64.8%) | 48 (68.6%) | 24 (58.5%) | 1.2 (0.8 - 1.5) | 0.19 |
Female | 39 (35.1%) | 22 (31.42%) | 17 (41.5%) | 0.7 (0.4 - 1.3) |
|
Age (years) |
|
|
|
|
|
≤39 | 24 (21.6%) | 6 (8.6%) | 18 (43.9%) | 0.6 (0.4 - 0.8) | 0.00 |
[40 - 59] | 47 (42.3%) | 33 (47.1%) | 14 (34.1%) | 1.3 (0.8 - 2.2) | 0.12 |
≥60 | 40 (36%) | 30 (42.8%) | 10 (24.4%) | 2.1 (1.2 - 3.8) | 0.04 |
FRCV |
|
|
|
|
|
Hypertension | 66 (59.4%) | 51 (72.85%) | 15 (36.5%) | 1.9 (1.2 - 3) | 0.00 |
Diabetes | 15 (13.5%) | 13 (18.6%) | 2 (4.9%) | 3.8 (0.9 - 16) | 0.03 |
STROKE | 5 (4.5%) | 4 (5.7%) | 1 (2.4%) | 2.3 (0.3 - 20) | 0.38 |
Obesity | 18 (16.2%) | 12 (17.1%) | 6 (14.6%) | 1.1 (0.4 - 2.8) | 0.47 |
Other chronic conditions |
|
|
|
| |
ARF | 17 (15.3%) | 16 (22.9%) | 1 (4%) | 94 (1.3 - 68.1) | 0.02 |
Clinical parameters |
|
|
|
|
|
Overall CI | 72 (64.8%) | - | - | - | - |
Left CI | 19 (17.1%) | 12 (16.6%) | 7 (17%) | 0.9 (0.8 - 1.2) | 0.52 |
Right CI | 11 (9.9%) | 6 (8.3%) | 5 (12.1) | 1.1 (0.8 - 1.4) | 0.29 |
Normal MAP | 13 (11.7%) | 11 (40.1%) | 2 (4.9%) | 0.7 (0.5 - 0.9) | 0.07 |
Biological parameters Haemoglobin (g/dl) |
|
|
| ||
>12 | 65 (58.5%) | 45 (64.3%) | 20 (48.8%) | 1.3 (0.9 - 1.7) | 0.08 |
[10 - 12] | 32 (28.8%) | 20 (28.6%) | 12 (29.3%) | 0.9 (0,7 - 1,3) | 0.55 |
<10 | 14 (12.6%) | 5 (7.14%) | 9 (22%) | 0.5 (0.3 - 1) | 0.02 |
Morphological parameters |
|
|
|
| |
HVG (Yes) | 39 (35.1%) | 27 (38.6%) | 12 (29.3%) | 1.15 (0.9 - 1.5) | 0.2 |
ACFA (Yes) | 25 (22.5%) | 18 (25.7%) | 7 (17.1%) | 1.2 (0.8 - 1.6) | 0.2 |
ESV (Yes) | 13 (11.7%) | 8 (11.4%) | 5 (12.2) | 0.9 (0.6 - 1.5) | 0.5 |
Cardiomegaly | 72 (64.8%) | 69 (98.6%) | 3 (3.6%) | 1.03 (0.9 - 1.08) | 0.39 |
Preserved LVEF | 28 (25.2%) | 18 (25.7%) | 10 (24.4%) | 0.9 (0.7 - 1.3) | 0.53 |
Lowered mean LVEF | 11 (9.9%) | 8 (11.4%) | 3 (7.3%) | 1.5 (0.4 - 5.5) | 0.36 |
Impaired LVEF | 83 (74.7%) | 52 (74.3%) | 31 (75.6%) | 0.9 (0.8 - 1.2) | 0.5 |
High PRVG | 68 (61.2%) | 58 (82.8%) | 10 (24.4%) | 0.8 (0.5 - 1.2) | 0.2 |